Celsion (CLSN) Announces Encouraging Data from GEN-1 Phase 1b Dose-Escalation Trial
Go back to Celsion (CLSN) Announces Encouraging Data from GEN-1 Phase 1b Dose-Escalation TrialCELSION (NASDAQ: CLSN) | Delayed: 1.96 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.96 | 52 Week High | $2.31 | |||
Open | $1.96 | 52 Week Low | $0.82 | |||
Day High | $1.96 | P/E | N/A | |||
Day Low | $1.96 | EPS | $-1.79 | |||
Volume | 1 |